Vaccine-derived poliovirus cases reported in 39 countries during surveillance period

A surveillance report documented cases of vaccine-derived polioviruses worldwide from January 2023 through June 2024. The report indicated these cases occurred in 39 countries, but did not specify the affected population, sample size, or specific interventions or exposures being monitored. No quantitative data on case numbers, effect sizes, or statistical measures were provided.

Safety and tolerability information was not reported in this surveillance document. The report did not include details on adverse events, serious adverse events, or discontinuations related to any interventions.

Key limitations include the absence of population characteristics, intervention details, and quantitative outcome measures. The report's practice relevance is limited to surveillance awareness, as it provides no data to guide clinical decision-making about prevention or treatment. Funding sources and potential conflicts of interest were not disclosed.